We serve Chemical Name:5-(2,4-Dichlorophenyl)-2-furaldehyde CAS:56300-69-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(2,4-Dichlorophenyl)-2-furaldehyde
CAS.NO:56300-69-7
Synonyms:MFCD00141622;5-(2,4-dichlorophenyl)furan-2-carbaldehyde
Molecular Formula:C11H6Cl2O2
Molecular Weight:241.07000
HS Code:2932190090
Physical and Chemical Properties:
Melting point:158-163ºC(lit.)
Boiling point:359.7ºC at 760 mmHg
Density:1.392g/cm3
Index of Refraction:1.605
PSA:30.21000
Exact Mass:239.97400
LogP:4.06590
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like MFCD00141622 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(2,4-dichlorophenyl)furan-2-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(2,4-dichlorophenyl)furan-2-carbaldehyde Use and application,5-(2,4-dichlorophenyl)furan-2-carbaldehyde technical grade,usp/ep/jp grade.
Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 5-(2,4-Dichlorophenyl)-2-furaldehyde manufacturer GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. 5-(2,4-Dichlorophenyl)-2-furaldehyde supplier The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). 5-(2,4-Dichlorophenyl)-2-furaldehyde vendor ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� 5-(2,4-Dichlorophenyl)-2-furaldehyde factory Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching.
